Dynamic Technology Lab’s Aurinia Pharmaceuticals AUPH Stock Holding History

Dynamic Technology Lab’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,729	Closed	-$187K	–	875
2025 Q4	$187K	Buy	+11,729	New	+$166K	0.04%	633
2025 Q1	–	Sell	-20,509	Closed	-$185K	–	997
2024 Q4	$185K	Buy	+20,509	New	+$167K	0.03%	773
2024 Q2	–	Sell	-17,444	Closed	-$87K	–	945
2024 Q1	$87K	Buy	+17,444	New	+$118K	0.01%	975
2022 Q3	–	Sell	-46,482	Closed	-$467K	–	1119
2022 Q2	$467K	Buy	+46,482	New	+$520K	0.05%	612
2021 Q1	–	Sell	-19,541	Closed	-$270K	–	1133
2020 Q4	$270K	Buy	+19,541	New	+$284K	0.04%	709
2019 Q2	–	Sell	-15,279	Closed	-$99K	–	950
2019 Q1	$99K	Buy	+15,279	New	+$101K	0.02%	896
2018 Q1	–	Sell	-21,093	Closed	-$96K	–	1034
2017 Q4	$96K	Buy	+21,093	New	+$117K	0.02%	941

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Dynamic Technology Lab's AUPH Position: Q1 2026 in Review

Dynamic Technology Lab sold out of Aurinia Pharmaceuticals (AUPH) in Q1 2026, closing a stake of 11,729 shares — an estimated $187K sold.

Dynamic Technology Lab first reported a position in AUPH in Q4 2017 and held it in 7 quarters. The position peaked at $467K in Q2 2022. 260 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.

Dynamic Technology Lab reported no remaining Aurinia Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Dynamic Technology Lab sold 11,729 Aurinia Pharmaceuticals shares in Q1 2026, an estimated $187K.
Dynamic Technology Lab first reported a position in Aurinia Pharmaceuticals in Q4 2017 and held it in 7 quarters.
Dynamic Technology Lab's Aurinia Pharmaceuticals position peaked at $467K in Q2 2022.
260 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.

Based on Dynamic Technology Lab's 13F filing for Q1 2026, filed 15 May 2026.